Global biotech investors are stepping up activity in Singapore, as the city-state leverages its talent base, R&D strengths and EDB-backed incentives to anchor Asia-Pacific life sciences growth.
Global biotech investors are stepping up activity in Singapore, as the city-state leverages its talent base, R&D strengths and EDB-backed incentives to anchor Asia-Pacific life sciences growth.